European researchers discovered how drugs bind to the enzyme DHODH, which could lead to more selective cancer drugs.

A team at Duke University has created the first functioning human muscle from skin cell-derived induced pluripotent stem cells.

Alnylam, which put its hemophilia program on hold in September, has gotten the all-clear from the FDA to resume trials.

Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.

Engineers at Duke University say they’ve created an artificial heart muscle that helps repair damage in patients who have suffered heart attacks.

AstraZeneca is allowing U.K. scientists access to an early-stage pipeline med in the hope it can help patients with head and neck cancer.

Scientists have identified viral changes and antibody features that could provide a possible template for HIV vaccine design.

Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms.

The enzyme PTK6 could be targeted to quell the growth of estrogen receptor-positive breast cancer, a common form of the disease.